Millennium Management’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding CPRX
VCM
DM
VPM
Millennium Management's CPRX Position: Q1 2026 in Review
Millennium Management reduced its Catalyst Pharmaceutical (CPRX) stake by 23% in Q1 2026, selling an estimated $5.4M and leaving 766,991 shares worth $19M. The position accounts for 0.01% of the portfolio, ranked #1600.
Millennium Management first reported a position in CPRX in Q3 2014 and has held it in 42 quarters since. The position peaked at $43M in Q4 2022. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.
- Millennium Management held 766,991 shares of Catalyst Pharmaceutical worth $19M as of Q1 2026.
- Millennium Management sold 226,656 Catalyst Pharmaceutical shares in Q1 2026, an estimated $5.4M.
- Catalyst Pharmaceutical made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1600 holding.
- Millennium Management first reported a position in Catalyst Pharmaceutical in Q3 2014 and has held it in 42 quarters since.
- Millennium Management's Catalyst Pharmaceutical position peaked at $43M in Q4 2022.
- 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.
Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.